Xuewen Liu
No.138, Tongzipo Road
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.
Journal: Future oncology (London, England)
Published: June 03, 2026
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Journal: Lancet (London, England)
Published: April 23, 2026
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026
Revisiting nature of stage III non-small cell lung cancer: Anatomically defined, biologically systemic.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: December 16, 2025
Neoadjuvant immunotherapy plus chemotherapy in locally advanced stage III NSCLC patients undergoing definitive chemo-radiotherapy---a real‑world multicenter retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 08, 2025
Erratum to "Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA".
Journal: Biomaterials research
Published: September 24, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2025
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.
Journal: Lancet (London, England)
Published: July 23, 2025
International guidelines on the diagnosis and treatment of NUT carcinoma.
Journal: Innovation (Cambridge (Mass.))
Published: April 11, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.
Journal: Cancer biology & medicine
Published: April 09, 2025
A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells.
Journal: Biomaterials science
Published: January 21, 2025
Optimal dose-volume histogram thresholds for radiation pneumonitis prevention in lung cancer patients receiving immunotherapy.
Journal: Radiation oncology (London, England)
Published: November 12, 2024
Last Updated: 09/26/2026